Finding the molecular switches behind new infectious diseases
Quick summary
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Key takeaways
- Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Why it matters
“Finding the molecular switches behind new infectious diseases” illustrates how changes in the AI ecosystem can affect products, workflows and user expectations together. Its lasting significance depends on measurable adoption, cost and safety outcomes.
